Cargando…
Escaping Antiangiogenic Therapy: Strategies Employed by Cancer Cells
Tumor angiogenesis is widely recognized as one of the “hallmarks of cancer”. Consequently, during the last decades the development and testing of commercial angiogenic inhibitors has been a central focus for both basic and clinical cancer research. While antiangiogenic drugs are now incorporated int...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037767/ https://www.ncbi.nlm.nih.gov/pubmed/27608016 http://dx.doi.org/10.3390/ijms17091489 |